We always think of our customers with an open mind
Press Release
NTL signs an Exclusive Distribution Agreement with Huons MediTech for the Women's Medical Device “JILL SOF”
Author
엔티엘헬스케어
Date
2023-05-31 11:43
Views
193
NTL signs an Exclusive Distribution Agreement with Huons MediTech for the Women's Medical Device “JILL SOF”
NTL Healthcare, Korean obstetrics and gynecology specialized company, has joined forces with Huons MediTech.
On the 2nd, NTL Healthcare announced that it has signed a business agreement with Huons MediTech for the domestic exclusive distribution for “JILL SOF” and “V-Needle.”
Through this agreement, NTL Healthcare has enabled exclusive distribution of Huons MediTech's “JILL SOF”, and is currently in the process of sales targeting obstetrics and gynecology clinics and hospitals nationwide.
“JILL SOF" and "V-Needle" are women's medical devices developed for injecting drugs into the vaginal area. "JILL SOF" is equipped with a pressure sensing automatic injection system and hardware specialized for vaginal procedures. It can also be customized for each patient by adjusting the amount and speed of drug injection.
In addition, "V-Needle" is a needle designed exclusively for "JILL SOF" to enable more accurate and faster drug injection into the vaginal area. Its feature is that it can safely inject a quantified amount of drug in the precise location.
Through this business partnership that combines technology of Huons MediTech and obstetrics and gynecology network of NTL Healthcare, there is an expectation that the spread of the use of 'JILL SOF' will be accelerated.
Tae-hee Kim, CEO of NTL Healthcare, said, "I believe that “JILL SOF” and “V-Needle” can help to reduce the discomfort of women suffering from vaginal dryness and sexual intercourse and improve their quality of life."
Meanwhile, NTL Healthcare, which introduced cervical magnification imaging and reading system in Korea in 1996, recently obtained an export approval for its artificial intelligence (AI) image reading and screening system, 'CerviCARE® AI', which has learned from cervical cancer images big data.
In addition, NTL provides various screening services such as cancer screening for women, including cervical cancer screening, and plans to continuously develop and supply new products that can improve women's health.
NTL Healthcare, Korean obstetrics and gynecology specialized company, has joined forces with Huons MediTech.
On the 2nd, NTL Healthcare announced that it has signed a business agreement with Huons MediTech for the domestic exclusive distribution for “JILL SOF” and “V-Needle.”
Through this agreement, NTL Healthcare has enabled exclusive distribution of Huons MediTech's “JILL SOF”, and is currently in the process of sales targeting obstetrics and gynecology clinics and hospitals nationwide.
“JILL SOF" and "V-Needle" are women's medical devices developed for injecting drugs into the vaginal area. "JILL SOF" is equipped with a pressure sensing automatic injection system and hardware specialized for vaginal procedures. It can also be customized for each patient by adjusting the amount and speed of drug injection.
In addition, "V-Needle" is a needle designed exclusively for "JILL SOF" to enable more accurate and faster drug injection into the vaginal area. Its feature is that it can safely inject a quantified amount of drug in the precise location.
Through this business partnership that combines technology of Huons MediTech and obstetrics and gynecology network of NTL Healthcare, there is an expectation that the spread of the use of 'JILL SOF' will be accelerated.
Tae-hee Kim, CEO of NTL Healthcare, said, "I believe that “JILL SOF” and “V-Needle” can help to reduce the discomfort of women suffering from vaginal dryness and sexual intercourse and improve their quality of life."
Meanwhile, NTL Healthcare, which introduced cervical magnification imaging and reading system in Korea in 1996, recently obtained an export approval for its artificial intelligence (AI) image reading and screening system, 'CerviCARE® AI', which has learned from cervical cancer images big data.
In addition, NTL provides various screening services such as cancer screening for women, including cervical cancer screening, and plans to continuously develop and supply new products that can improve women's health.
